Yantian Zeng – Trademark Portfolio

Entity Type: 01

Yantian Zeng holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 11 (Environmental Control) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include AMANKOS and NURBINI. The owner is based in Huizhou,Guangdong.

No.29,Dist 1,Xiaxin Group,Xiaotie

Xiaojinkou Office,Huicheng District

Huizhou,Guangdong 516000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AMANKOS
AMANKOS
Registered 2021
NURBINI
NURBINI
Registered 2020

Trademark Classifications

Yantian Zeng's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

11
Environmental Control (1 filing)

Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Yantian Zeng have?

Yantian Zeng has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Yantian Zeng file in?

Yantian Zeng files trademarks across 2 Nice Classification classes. The most active classes are Class 11 (Environmental Control), Class 10 (Medical Apparatus). Class 11 covers apparatus for lighting, heating, steam generating, cooking, refrigerating, drying.

What are Yantian Zeng's most well-known trademarks?

Yantian Zeng's registered trademark portfolio includes well-known marks such as AMANKOS and NURBINI. These are among 2 currently registered trademarks in the portfolio.

What is Yantian Zeng's trademark registration success rate?

Yantian Zeng has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.